KaloBios Pharma (NASDAQ: KBIO) 32.6% LOWER; announced that it will reduce its workforce as part of a plan to reduce ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Early 'NBA 2K' Strength Pushes 2Q Beat for Take-Two Interactive Software (TTWO); Mizuho Securities Raises Price target to $37 November 6, 2015 9:24 AM 'NBA 2K' Strength Leads Take-Two Interactive Software (TTWO) to Revenue Beat; Wedbush Raises Price Target to $29.50 November 6, 2015 9:07 AM License Growth Drives Tableau Software (DATA) to 3Q Revenue Beat; Wedbush Reiterates Outperform November 6, 2015 8:56 AM Skullcandy's (SKUL) Higher-Than-Expected Gross Margin Offset Low Revenue; Roth Capital Reiterates Buy November 6, 2015 8:37 AM